Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: A systematic review

European Journal of Surgical Oncology

Volumn 39, Issue 4, 2013, Pages 311-319

  Bhangu, A ^a   Broom, L ^a   Nepogodiev, D ^a   Gourevitch, D ^a   Desai, A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Isolated limb perfusion; Sarcoma; Soft tissue sarcoma; TNF

Indexed keywords

MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

CANCER RECURRENCE; FOLLOW UP; HUMAN; ISOLATED LIMB PERFUSION; LIMB AMPUTATION; LIMB PERFUSION; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMPUTATION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; LIMB SALVAGE; MELPHALAN; NEOPLASM RECURRENCE, LOCAL; RECURRENCE; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875215855     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.12.018     Document Type: Review

References (42)

1. R. Grimer, I. Judson, D. Peake, and B. Seddon Guidelines for the management of soft tissue sarcomas Sarcoma 2010 506182
2. J.R. Toro, L.B. Travis, H.J. Wu, K. Zhu, C.D. Fletcher, and S.S. Devesa Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases Int J Cancer 119 12 2006 2922 2930
3. A.A. Bhangu, J.A. Beard, and R.J. Grimer Should soft tissue sarcomas be treated at a specialist centre? Sarcoma 8 1 2004 1 6
4. O. Creech Jr., E.T. Krementz, R.F. Ryan, and J.N. Winblad Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit Ann Surg 148 4 1958 616 632
5. A.M. Eggermont, J.H. de Wilt, and T.L. ten Hagen Current uses of isolated limb perfusion in the clinic and a model system for new strategies Lancet Oncol 4 7 2003 429 437
6. A.T. Stotter, R.P. A'Hern, C. Fisher, A.F. Mott, M.E. Fallowfield, and G. Westbury The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival Cancer 65 5 1990 1119 1129
7. P. Gustafson, B. Rooser, and A. Rydholm Is local recurrence of minor importance for metastases in soft tissue sarcoma? Cancer 67 8 1991 2083 2086
8. D. Lienard, P. Ewalenko, J.J. Delmotte, N. Renard, and F.J. Lejeune High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma J Clin Oncol 10 1 1992 52 60
9. A.M. Eggermont, H. Schraffordt Koops, and J.M. Klausner Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience Ann Surg 224 6 1996 756 764
10. A.M. Eggermont Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma Surg Oncol Clin N Am 12 2 2003 469 483
11. M.B. Lens, and M. Dawes Isolated limb perfusion with melphalan in the treatment of malignant melanoma of the extremities: a systematic review of randomised controlled trials Lancet Oncol 4 6 2003 359 364
12. D. Moreno-Ramirez, L. de la Cruz-Merino, L. Ferrandiz, R. Villegas-Portero, and A. Nieto-Garcia Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety Oncologist 15 4 2010 416 427
13. A.M. Eggermont, F. Brunstein, D. Grunhagen, and T.L. ten Hagen Regional treatment of metastasis: role of regional perfusion. State of the art isolated limb perfusion for limb salvage Ann Oncol 15 Suppl. 4 2004 iv107 iv112
14. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 2000 205 216
15. J. Wieberdink, C. Benckhuysen, R.P. Braat, E.A. van Slooten, and G.A. Olthuis Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions Eur J Cancer Clin Oncol 18 10 1982 905 910
16. R. Harbour, and J. Miller A new system for grading recommendations in evidence based guidelines Brit Med J 323 7308 2001 334 336
17. E. Stoeckle, H. Gardet, and J.M. Coindre Prospective evaluation of quality of surgery in soft tissue sarcoma Eur J Surg Oncol 32 10 2006 1242 1248
18. S. Cherix, M. Speiser, and M. Matter Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients J Surg Oncol 98 3 2008 148 155
19. M.L. Hoven-Gondrie, E. Bastiaannet, R.J. van Ginkel, A.J. Suurmeijer, and H.J. Hoekstra TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome J Surg Oncol 103 7 2011 648 655
20. S. Bonvalot, A. Laplanche, and F. Lejeune Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better? Ann Oncol 16 7 2005 1061 1068
21. I. Nachmany, A. Subhi, and I. Meller Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma Eur J Surg Oncol 35 2 2009 209 214
22. E. Pennacchioli, M. Deraco, and L. Mariani Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution Ann Surg Oncol 14 2 2007 553 559
23. C.J. Wray, R.S. Benjamin, K.K. Hunt, J.N. Cormier, M.I. Ross, and B.W. Feig Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials Cancer 117 14 2011 3235 3241
24. K.M. Thijssens, R.J. van Ginkel, E. Pras, A.J. Suurmeijer, and H.J. Hoekstra Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy Ann Surg Oncol 13 4 2006 518 524
25. J.P. Deroose, J.W. Burger, and A.N. van Geel Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients? Ann Surg Oncol 18 2 2011 321 327
26. C.R. Rossi, A. Vecchiato, M. Foletto, D. Nitti, V. Ninfo, and A. Fornasiero Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas Cancer 73 8 1994 2140 2146
27. M.L. Hoven-Gondrie, K.M. Thijssens, J.H. Geertzen, E. Pras, R.J. van Ginkel, and H.J. Hoekstra Isolated limb perfusion and external beam radiotherapy for soft tissue sarcomas of the extremity: long-term effects on normal tissue according to the LENT-SOMA scoring system Ann Surg Oncol 15 5 2008 1502 1510
28. J.P. Deroose, A.M. Eggermont, A.N. van Geel, J.W. Burger, M.A. den Bakker, and J.H. de Wilt Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas J Clin Oncol 29 30 2011 4036 4044
29. K.M. Thijssens, J.E. Hoekstra-Weebers, R.J. van Ginkel, and H.J. Hoekstra Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma Ann Surg Oncol 13 6 2006 864 871
30. S. Bonvalot, F. Rimareix, and S. Causeret Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient Ann Surg Oncol 16 12 2009 3350 3357
31. D.J. Grunhagen, J.H. de Wilt, W.J. Graveland, A.N. van Geel, and A.M. Eggermont The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma Cancer 106 1 2006 156 162
32. A.F. Olieman, R.J. van Ginkel, W.M. Molenaar, H. Schraffordt Koops, and H.J. Hoekstra Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile? Arch Orthop Trauma Surg 118 1-2 1998 70 74
33. P.J. Woll, P. Reichardt, and A. Le Cesne Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial Lancet Oncol 13 10 2012 1045 1054
34. F. Di Filippo, D. Giannarelli, and C. Botti Hyperthermic antiblastic perfusion for the treatment of soft tissue limb sarcoma Ann Oncol 3 Suppl. 2 1992 S71 S74
35. F. Di Filippo, F. Cavaliere, and M. Anza Liposomal doxorubicin in the perfusional treatment of advanced soft tissue limb sarcoma J Chemother 16 Suppl 5 2004 66 69
36. A. Eroglu, H. Kocaoglu, S. Demirci, and H. Akgul Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity Eur J Surg Oncol 26 3 2000 213 221
37. F. Grabellus, C. Kraft, and S.Y. Sheu Evaluation of 47 soft tissue sarcoma resection specimens after isolated limb perfusion with TNF-alpha and melphalan: histologically characterized improved margins correlate with absence of recurrences Ann Surg Oncol 16 3 2009 676 686
38. M. Gutman, M. Inbar, and D. Lev-Shlush High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation Cancer 79 6 1997 1129 1137
39. A.J. Hayes, S.J. Neuhaus, M.A. Clark, and J.M. Thomas Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma Ann Surg Oncol 14 1 2007 230 238
40. H.S. Moseley An evaluation of two methods of limb salvage in extremity soft-tissue sarcomas Arch Surg 127 10 1992 1169 1173 discussion 73-4
41. E.M. Noorda, B.C. Vrouenraets, O.E. Nieweg, F. van Coevorden, G.W. van Slooten, and B.B. Kroon Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities Cancer 98 7 2003 1483 1490
42. C.R. Rossi, M. Foletto, and S. Mocellin Hyperthermic isolated perfusion with low-dose TNFalpha and doxorubicin in patients with locally advanced soft tissue limb sarcomas J Chemother 16 Suppl. 5 2004 58 61